TRAMIX
The image of the packaging corresponds to the packaging currently registered with the regulatory authorities of Ukraine.
In case of any discrepancies, please contact us at tel. +380 44 490 75 22

Solution for injection 5 ml №5.
The image of the packaging corresponds to the packaging currently registered with the regulatory authorities of Ukraine.
In case of any discrepancies, please contact us at tel. +380 44 490 75 22

-
Bleeding or risk of bleeding risk with increasing fibrinolysis both generalized (bleeding during surgery and in the postoperative period, postpartum haemorrhage, manual separation of placenta, placental chorionic, bleeding during pregnancy, malignancy, pancreatic and prostate cancer, haemophilia, haemorrhagic complications in fibrinolytic therapy, thrombocytopenic purpura, leukaemia, liver diseases, previous therapy with streptokinase) and local (uterine, nasal, pulmonary, gastrointestinal bleeding, haematuria, bleeding after prostatectomy, cervical conisation due to carcinoma, tooth extraction in patients with haemorrhagic diathesis). Surgeries on the bladder. Surgical manipulations in systemic inflammatory response (sepsis, peritonitis, necrotizing pancreatitis, severe and moderate gestational toxicosis, shock of different aethiology and other critical states).
-
1 ml of solution contains 100 mg of tranexamic acid on a 100% substance basis.